Dihydrothienopyrimidine for treating inflammatory disorders

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 495/04 (2006.01) A61K 31/519 (2006.01) A61P 29/00 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2647243

The invention relates to a new dihydrothienopyrimidine for formula (1), as well as pharmacologically tolerable salts, diastereomers, enantiomers, racemates, hydrates or solvates thereof, wherein X SO or SO2, preferably, however, SO, and wherein R1, R2 and R3 have that significance expressed in the description and that are suited for treatment of respiratory or gastrointestinal complaints or disorders, inflammatory disorders of the joints, skin, or eyes, diseases of the peripheral or central nervous system or cancer, as well as pharmaceutical compositions that contain this bond.

L'invention concerne de nouvelles dihydrothiénopyrimidines de formule (1), ainsi que des sels, des diastéréomères, des énantiomères, des racémates, des hydrates ou des solvates de celles-ci pharmaceutiquement acceptables, dans laquelle X représente SO ou SO2, de préférence SO toutefois, et dans laquelle R1, R2 et R3 ont la signification définie dans la description, et qui sont appropriées pour le traitement de douleurs ou de maladies gastro-intestinales ou du système respiratoire, de maladies inflammatoires des articulations, de la peau ou des yeux, de maladies du système nerveux périphérique ou central ou de cancers, ainsi que des compositions pharmaceutiques, qui contiennent ces composés.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Dihydrothienopyrimidine for treating inflammatory disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dihydrothienopyrimidine for treating inflammatory disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dihydrothienopyrimidine for treating inflammatory disorders will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1886825

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.